Intervention

DB-1303/BNT323

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting1

Common conditions3

Lead sponsors shown1

Clinical trials

3 shown

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsNCT05150691 · 2022-01-31

A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast CancerNCT06265428 · 2024-01-29

ACTIVE_NOT_RECRUITING

A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)NCT06018337 · 2024-01-18

ACTIVE_NOT_RECRUITING

Common conditions

HER2-positive Advanced Solid Tumor1 HER2-positive Breast Cancer1 Metastatic Breast Cancer1

Leading sponsors

DualityBio Inc.3

Trial status mix

ACTIVE_NOT_RECRUITING2

RECRUITING1

Phase mix

PHASE32

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.